Teladoc Health (NYSE: TDOC) director J. Eric Evans plans 2026 retirement

Rhea-AI Filing Summary

Teladoc Health, Inc. disclosed that board member J. Eric Evans plans to retire from its Board of Directors. He informed the company on December 11, 2025 that he will not stand for reelection at Teladoc Health’s 2026 Annual Meeting of Stockholders and will retire from the Board at the conclusion of that meeting.

Mr. Evans has served as a director since 2023. The company notes that he is retiring for personal reasons and that his decision is not due to any disagreement with Teladoc Health on any matter.

FALSE0001477449155 E 44th StreetSuite 1700New YorkNY1001700014774492025-10-172025-10-170001477449dei:FormerAddressMember2025-10-172025-10-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________________________

FORM 8-K

___________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 11, 2025

___________________________________

Teladoc Health, Inc.

(Exact name of registrant as specified in its charter)

___________________________________

Delaware (State or other jurisdiction of incorporation)			001-37477 (Commission File Number)			04-3705970 (I.R.S. Employer Identification No.)
155 E 44th Street Suite 1700 New York, NY 10017
(Address of principal executive offices and zip code)
(203) 635-2002

___________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol			Name of each exchange on which registered
Common stock, par value $0.001 per share			TDOC			The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 11, 2025, Mr. J. Eric Evans notified Teladoc Health, Inc. (the “Company”) of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the conclusion of the Annual Meeting. Mr. Evans has been a director of the Company since 2023 and the Company thanks him for his dedicated service. Mr. Evans has indicated that he is retiring from the Board for personal reasons and not because of any disagreement with the Company on any matter.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 16, 2025

Teladoc Health, Inc.
By:			/s/ Adam C. Vandervoort
Name:			Adam C. Vandervoort
Title:			Chief Legal Officer and Secretary

FAQ

What board change did Teladoc Health (TDOC) announce?

Teladoc Health announced that director J. Eric Evans will retire from its Board of Directors. He has notified the company that he will not stand for reelection at the 2026 Annual Meeting of Stockholders and will retire at the conclusion of that meeting.

When will J. Eric Evans retire from the Teladoc Health (TDOC) board?

J. Eric Evans will retire from the Teladoc Health Board of Directors effective at the conclusion of the company’s 2026 Annual Meeting of Stockholders.

How long has J. Eric Evans served on Teladoc Health’s board?

J. Eric Evans has been a director of Teladoc Health since 2023, according to the company’s disclosure.

Why is J. Eric Evans leaving the Teladoc Health (TDOC) board?

Teladoc Health states that Mr. Evans is retiring from the Board for personal reasons and that his decision is not because of any disagreement with the company on any matter.

Does Teladoc Health report any disagreement with J. Eric Evans?

No. Teladoc Health specifies that Mr. Evans is retiring for personal reasons and not due to any disagreement with the company on any matter.

Who signed the Teladoc Health disclosure about the board change?

The disclosure was signed on behalf of Teladoc Health by Adam C. Vandervoort, who is identified as the company’s Chief Legal Officer and Secretary.